Affordable Access

Publisher Website

A population-based nested case-control study in taiwan: use of 5α-reductase inhibitors did not decrease prostate cancer risk in patients with benign prostate hyperplasia.

Authors
Type
Published Article
Journal
The oncologist
Publication Date
Volume
17
Issue
7
Pages
986–991
Identifiers
DOI: 10.1634/theoncologist.2011-0464
PMID: 22723508
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments